openPR Logo
Press release

Gastric Cancer Drugs Market Report By Route Of Administration, Type, End Users - Global Forecast To 2032

Gastric Cancer Drugs Market

Gastric Cancer Drugs Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per the gastric cancer drugs market report by The Business Research Company, an increasing number of obesity cases and the smoking population increased the number of people suffering from gastric cancer. Consuming tobacco and following diet unhealthy diet increases the risk of stomach cancer.

The global gastric cancer drugs market size will grow from $3.02 billion in 2022 to $3.38 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global gastric cancer drugs market size is expected to grow to $5.03 billion in 2027 at a CAGR of 10.5%.

Read More On The Gastric Cancer Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report

Major competitors in the gastric cancer drugs market include Eli Lilly and company, Novartis, Merck KGaA, Otsuka Pharmaceutical, F. Hoffmann-La Roche, GlaxoSmithKline PLC., Bristol-Myers Squibb, Sanofi, Pfizer Inc., AstraZeneca, Bayer Healthcare, Abbott, AROG Pharmaceuticals, Ipsen Biopharmaceuticals, Array Biopharma, Taiho Oncology, AstraZeneca, ARIAD Pharmaceuticals, Ono Pharmaceutical, Jiangsu HengRui Medicine, Gilead Bioscience, Celgene/Taiho, Boston Biomedical, Imugene Limited, Boehringer Ingelheim, Daiichi-Sankyo, Danaher corporation.

The gastric cancer drugs market is segmented -
• By Type: Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab

• By End User: Hospitals, Clinics, Other End-users

• By Route of Administration: Oral, Parenteral

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the gastric cancer drugs market.

Request A Free Sample Of The Gastric Cancer Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2603&type=smp

Gastric cancer drugs refer to anti-cancer medications that are taken orally as pills or are injected into a vein (via an IV line or central venous catheter). This treatment is effective for cancer that has spread to organs other than those where it originated since these medications penetrate the bloodstream and reach every part of the body.

The Table Of Content For The Gastric Cancer Drugs Market Include:
1. Executive Summary
2. Gastric Cancer Drugs Market Characteristics
3. Gastric Cancer Drugs Market Trends And Strategies
4. Gastric Cancer Drugs Market - Macro Economic Scenario
5. Gastric Cancer Drugs Market Size And Growth
6. Gastric Cancer Drugs Market Segmentation
……
27. Gastric Cancer Drugs Market Competitive Landscape And Company Profiles
28. Gastric Cancer Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Gastric Cancer Drugs Market
30. Gastric Cancer Drugs Market Future Outlook and Potential Analysis
31. Appendix

The "Global Gastric Cancer Drugs Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastric Cancer Drugs Market Report By Route Of Administration, Type, End Users - Global Forecast To 2032 here

News-ID: 2894708 • Views:

More Releases from The Business research company

Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Surgical Meshes Market Size By 2025? In the past few years, the market size of surgical meshes has seen significant growth. It is projected to expand from $2.03 billion in 2024 to $2.18 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 7.3%.
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accelerating Growth Trends
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accele …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rehabilitation Equipment Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a significant growth in the size of the rehabilitation equipment market. Projected to increase from $17.36 billion in 2024, it is expected to reach $18.49 billion in 2025, with a compound annual
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast to 2034
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pediatric Neurology Device Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pediatric neurology devices has seen significant expansion in recent years, climbing from $2.5 billion in 2024 to an anticipated $2.65 billion in 2025, reflecting a compound annual growth rate (CAGR)
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: Innovative Products Boosting Profitability in the Orthokeratology Lens Market
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Orthokeratology Lens Market Through 2025? The market for orthokeratology lenses has seen a significant increase in size over recent years. It's projected to expand from $2.56 billion in 2024 to $2.75 billion in 2025, with a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Gastric

Rising Gastric Cancer Cases Fuel Growth In Gastric Cancer Drugs Market Driving M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Cancer Drugs Market Size By 2025? In recent times, the market size for gastric cancer drugs has seen a swift expansion. Projections forecast growth from $4.41 billion in 2024 to $4.9 billion in 2025, a compound annual growth rate (CAGR) of 11.2%. Factors contributing
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driving Marke …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Gastric Ulcers Market Size By 2025? In the last few years, the market size for gastric ulcers has been expanding notably. It is anticipated to increase from $4.29 billion in 2024 to $4.54 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.9%.
Increasing Geriatric Population Fuels Gastric Ulcers Market Growth Driver: Leadi …
How Are the key drivers contributing to the expansion of the gastric ulcers market? The rising geriatric population is expected to accelerate the growth of the gastric ulcers market. The geriatric population, typically individuals aged 65 and above, is growing due to improvements in healthcare and increased life expectancy. This population is more susceptible to gastric ulcers due to factors like the use of NSAIDs and decreased mucosal protection. For instance,
Top Factor Driving Gastric Cancer Drugs Market Growth in 2025: Rising Gastric Ca …
What market dynamics are playing a key role in accelerating the growth of the gastric cancer drugs market? The rise in obesity and smoking rates has led to an increased prevalence of gastric cancer. Factors like tobacco use and poor dietary habits have been linked to a higher risk of developing this disease. As per data from the Government Digital Service in the UK, it was projected in May 2023 that
Gastric Cancer Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Gastric Cancer Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Gastric Cancer pipeline landscape. It covers the pipeline drug profiles, including Gastric Cancer clinical trials and nonclinical stage products. It also covers the Gastric Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Gastric Cancer
Gastric Function Test Market - Empowering Digestive Health: Gastric Function Tes …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Gastric Function Test Market. Gastric Function Test Market: https://www.growthplusreports.com/report/gastric-function-test-market/9126 The Gastric Function Test Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the